Coronavirus Test Kits Market in APAC 2021-2025
SKU ID : TNV-18569658 | Publishing Date : 25-May-2021 | No. of pages : 120
Detailed TOC of Coronavirus Test Kits Market in APAC 2021-2025
• Executive Summaryo Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Government - Market size and forecast 2020-2025
o Non-government - Market size and forecast 2020-2025
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o India - Market size and forecast 2020-2025
o China - Market size and forecast 2020-2025
o Japan - Market size and forecast 2020-2025
o South Korea (Republic of Korea) - Market size and forecast 2020-2025
o Rest of APAC - Market size and forecast 2020-2025
o Market opportunity by geography
• Drivers Challenges and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o 3D Biomedicine Science and Technology Co. Ltd.
o Abbott Laboratories
o BGI Genomics Co. Ltd.
o Co Diagnostics Inc.
o F. Hoffmann La Roche Ltd.
o Guangzhou Wondfo Biotech Co. Ltd.
o Maccura Biotechnology Co. Ltd.
o Mylab Discovery Solutions Pvt Ltd.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Parent market
• 8: Market characteristics
• 9: Offerings of vendors included in the market definition
• 10: Market segments
• 11: Global - Market size and forecast 2020 - 2025 ($ million)
• 12: Global market: Year-over-year growth 2020 - 2025 (%)
• 13: Five forces analysis 2020 & 2025
• 14: Bargaining power of buyers
• 15: Bargaining power of suppliers
• 16: Threat of new entrants
• 17: Threat of substitutes
• 18: Threat of rivalry
• 19: Market condition - Five forces 2020
• 20: End user - Market share 2020-2025 (%)
• 21: Comparison by End user
• 22: Government - Market size and forecast 2020-2025 ($ million)
• 23: Government - Year-over-year growth 2020-2025 (%)
• 24: Non-government - Market size and forecast 2020-2025 ($ million)
• 25: Non-government - Year-over-year growth 2020-2025 (%)
• 26: Market opportunity by End user
• 27: Customer landscape
• 28: Market share by geography 2020-2025 (%)
• 29: Geographic comparison
• 30: India - Market size and forecast 2020-2025 ($ million)
• 31: India - Year-over-year growth 2020-2025 (%)
• 32: China - Market size and forecast 2020-2025 ($ million)
• 33: China - Year-over-year growth 2020-2025 (%)
• 34: Japan - Market size and forecast 2020-2025 ($ million)
• 35: Japan - Year-over-year growth 2020-2025 (%)
• 36: South Korea (Republic of Korea) - Market size and forecast 2020-2025 ($ million)
• 37: South Korea (Republic of Korea) - Year-over-year growth 2020-2025 (%)
• 38: Rest of APAC - Market size and forecast 2020-2025 ($ million)
• 39: Rest of APAC - Year-over-year growth 2020-2025 (%)
• 40: Key leading countries
• 41: Market opportunity by geography ($ million)
• 42: Impact of drivers and challenges
• 43: Vendor landscape
• 44: Landscape disruption
• 45: Industry risks
• 46: Vendors covered
• 47: Market positioning of vendors
• 48: 3D Biomedicine Science and Technology Co. Ltd. - Overview
• 49: 3D Biomedicine Science and Technology Co. Ltd. - Product and service
• 50: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
• 51: 3D Biomedicine Science and Technology Co. Ltd. - Key customers
• 52: 3D Biomedicine Science and Technology Co. Ltd. - Segment focus
• 53: Abbott Laboratories - Overview
• 54: Abbott Laboratories - Business segments
• 55: Abbott Laboratories - Key offerings
• 56: Abbott Laboratories - Key customers
• 57: Abbott Laboratories - Segment focus
• 58: BGI Genomics Co. Ltd. - Overview
• 59: BGI Genomics Co. Ltd. - Product and service
• 60: BGI Genomics Co. Ltd. - Key offerings
• 61: BGI Genomics Co. Ltd. - Key customers
• 62: BGI Genomics Co. Ltd. - Segment focus
• 63: Co Diagnostics Inc. - Overview
• 64: Co Diagnostics Inc. - Business segments
• 65: Co Diagnostics Inc. - Key offerings
• 66: Co Diagnostics Inc. - Key customers
• 67: Co Diagnostics Inc. - Segment focus
• 68: F. Hoffmann La Roche Ltd. - Overview
• 69: F. Hoffmann La Roche Ltd. - Business segments
• 70: F. Hoffmann La Roche Ltd. - Key offerings
• 71: F. Hoffmann La Roche Ltd. - Key customers
• 72: F. Hoffmann La Roche Ltd. - Segment focus
• 73: Guangzhou Wondfo Biotech Co. Ltd. - Overview
• 74: Guangzhou Wondfo Biotech Co. Ltd. - Product and service
• 75: Guangzhou Wondfo Biotech Co. Ltd. - Key offerings
• 76: Guangzhou Wondfo Biotech Co. Ltd. - Key customers
• 77: Guangzhou Wondfo Biotech Co. Ltd. - Segment focus
• 78: Maccura Biotechnology Co. Ltd. - Overview
• 79: Maccura Biotechnology Co. Ltd. - Product and service
• 80: Maccura Biotechnology Co. Ltd. - Key offerings
• 81: Maccura Biotechnology Co. Ltd. - Key customers
• 82: Maccura Biotechnology Co. Ltd. - Segment focus
• 83: Mylab Discovery Solutions Pvt Ltd. - Overview
• 84: Mylab Discovery Solutions Pvt Ltd. - Product and service
• 85: Mylab Discovery Solutions Pvt Ltd. - Key offerings
• 86: Mylab Discovery Solutions Pvt Ltd. - Key customers
• 87: Mylab Discovery Solutions Pvt Ltd. - Segment focus
• 88: QIAGEN NV - Overview
• 89: QIAGEN NV - Business segments
• 90: QIAGEN NV - Key offerings
• 91: QIAGEN NV - Key customers
• 92: QIAGEN NV - Segment focus
• 93: Thermo Fisher Scientific Inc. - Overview
• 94: Thermo Fisher Scientific Inc. - Business segments
• 95: Thermo Fisher Scientific Inc. - Key offerings
• 96: Thermo Fisher Scientific Inc. - Key customers
• 97: Thermo Fisher Scientific Inc. - Segment focus
• 98: Currency conversion rates for US$
• 99: Research Methodology
• 100: Validation techniques employed for market sizing
• 101: Information sources
• 102: List of abbreviations